PTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna™ Slows Disease Progression in Patients with Duchenne Muscular Dystrophy October 9, 2019
Calithera Biosciences Completes Patient Enrollment in Randomized CANTATA Trial of Telaglenastat and Cabozantinib in Advanced Renal Cell Carcinoma October 3, 2019
Bicycle Therapeutics Announces Presentation of Updated Data from Phase I/IIa Trial Evaluating BT1718 in Patients with Advanced Solid Tumors September 30, 2019
